What is Lenalidomide?

Category: Prescription Drugs

Most popular types: Revlimid

false

See also: Bortezomib-lenalidomide-dexamethasone (VRd) Carfilzomib-lenalidomide-dexamethasone Cyclophosphamide-lenalidomide-dexamethasone Lenalidomide-bendamustine-dexamethasone Lenalidomide-dexamethasone (Rd) Melphalan-prednisone-lenalidomide (MPL)

Lenalidomide is an oral anticancer agent that may be used for the treatment of myelodysplastic syndrome (MDS), mantle cell lymphoma, and for the treatment of multiple myeloma.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple myeloma 139 123
Kaposi's sarcoma 2 1
Myelodysplastic syndrome 2 1
Inability to maintain personal safety 1 1
Non-Hodgkin's lymphoma 1 2
Participate in clinical trial 1 1

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
14
Moderate
53
Mild
42
None
18

Commonly reported side effects and conditions associated with Lenalidomide

Side effect Patients
Diarrhea 24
Fatigue 24
Neuropathy 5
Tiredness 5
Rashes (redness, swelling) 4
Constipation 3

Show all 85 reported side effects

Dosages

Based on patients currently taking Lenalidomide

Dosage Patients
10 mg daily 27
25 mg daily 14
15 mg daily 10
5 mg daily 5
25 mg every 3 weeks 3
20 mg daily 3
5 mg every 3 weeks 2
210 mg daily 2
210 mg every 3 weeks 1
35 mg daily 1

See all 13 dosages

Why patients stopped taking Lenalidomide

Multiple reasons could be selected

Reason Patients
Side effects too severe 11
Doctor's advice 8
Course of treatment ended 7
Did not seem to work 7
Other 3
See all 31 patients who've stopped taking Lenalidomide

Duration

Currently taking Lenalidomide

Duration Patients
1 - 6 months 4
6 months - 1 year 8
1 - 2 years 17
2 - 5 years 35
5 - 10 years 8
10 years or more 2

Stopped taking Lenalidomide

Duration Patients
Less than 1 month 8
1 - 6 months 8
6 months - 1 year 4
1 - 2 years 5
2 - 5 years 6
Adherence
Adherence Evaluations
Always 120
Usually 4
Sometimes 0
Never taken as prescribed 3
Burden
Burden Evaluations
Very hard to take 5
Somewhat hard to take 16
A little hard to take 14
Not at all hard to take 92
Cost per month
Cost per month Evaluations
$200+ 16
$100-199 4
$50-99 6
$25-49 19
< $25 51
Not specified 31

What people switch to and from

Patients started taking Lenalidomide after stopping:

Treatment Patients
Bortezomib (Velcade) 8
Bortezomib-lenalidomide-dexamethasone (VRd) 5
Bortezomib-dexamethasone (Vd) 2
Lenalidomide-dexamethasone (Rd) 2
Bortezomib-cyclophosphamide-dexamethasone (VCd or CyBorD) 1

Show all 8 treatments patients report switching from

Patients stopped taking Lenalidomide and switched to:

Treatment Patients
Bortezomib (Velcade) 4
Pomalidomide-dexamethasone 4
Carfilzomib (Kyprolis) 3
Ixazomib (Ninlaro) 3
Daratumumab (Darzalex) 2

Show all 12 treatments patients report switching to

Last updated:

1 patient evaluation for Lenalidomide

Feb 4, 2016 (Started Feb 01, 2016)

  • Effectiveness
    Major (for non-Hodgkin's lymphoma)
  • Side effects
    Severe (itchy scalp, edema (fluid retention), chest pain, breathing difficulty, heart palpitations)
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 20 mg Daily
Advice & Tips: Don't touch this stuff!
Cost: $50-99 monthly

Feb 1, 2016 (Started Feb 01, 2016)

  • Effectiveness
    Can't tell (for non-Hodgkin's lymphoma)
  • Side effects
    Severe
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 20 mg Daily
Cost: $50-99 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Lenalidomide